Cargando…
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis
In patients presenting with synchronous or metachronous multiple lung cancer (MLC), it is important to distinguish between multiple primary lung cancer (MP) and intrapulmonary metastasis (IM). The present study was aimed at investigating the mutational profiles of synchronous/metachronous MLC and to...
Autores principales: | Takahashi, Yuta, Shien, Kazuhiko, Tomida, Shuta, Oda, Shinsuke, Matsubara, Takehiro, Sato, Hiroki, Suzawa, Ken, Kurihara, Eisuke, Ogoshi, Yusuke, Namba, Kei, Yoshioka, Takahiro, Torigoe, Hidejiro, Yamamoto, Hiromasa, Soh, Junichi, Toyooka, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215894/ https://www.ncbi.nlm.nih.gov/pubmed/30216592 http://dx.doi.org/10.1111/cas.13797 |
Ejemplares similares
-
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma
por: Namba, Kei, et al.
Publicado: (2019) -
Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
por: Ogoshi, Yusuke, et al.
Publicado: (2019) -
Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells
por: Yoshioka, Takahiro, et al.
Publicado: (2019) -
Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer
por: Sato, Hiroki, et al.
Publicado: (2018) -
Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
por: Torigoe, Hidejiro, et al.
Publicado: (2018)